Literature DB >> 23291983

Role of microRNAs in breast cancer.

Ramesh Singh1, Yin-Yuan Mo.   

Abstract

MicroRNAs (miRNAs) are a class of post-transcriptional gene regulators with critical functions in normal cellular processes as well as disease processes. They are small molecules with 18~23 nucleotides in length. Since their early discovery in 1993, a large number of miRNAs have been characterized and analyzed to understand their pivotal role and their impact in a myriad of biological processes. Substantial research on miRNA highlights the involvement of these tiny RNAs in the etiopathogenesis of a variety of human diseases such as cancer, neuro-degenerative disorders, diabetes, cardiac hypertrophy and respiratory diseases. In this review, we update on recent advances of the emerging role of miRNAs in breast cancer and their clinical implications.

Entities:  

Keywords:  breast cancer; chemoresistance; microRNAs

Mesh:

Substances:

Year:  2013        PMID: 23291983      PMCID: PMC3595302          DOI: 10.4161/cbt.23296

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  171 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  A microRNA expression signature characterizing the properties of tumor-initiating cells for breast cancer.

Authors:  Lixin Wang; Daoqiang Zhang; Changwen Zhang; Shuping Zhang; Zhe Wang; Chen Qu; Sijin Liu
Journal:  Oncol Lett       Date:  2011-09-28       Impact factor: 2.967

3.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells.

Authors:  Philip K Lim; Sarah A Bliss; Shyam A Patel; Marcelo Taborga; Meneka A Dave; Larissa A Gregory; Steven J Greco; Margarette Bryan; Prem S Patel; Pranela Rameshwar
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

4.  Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells.

Authors:  F Yu; H Deng; H Yao; Q Liu; F Su; E Song
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

5.  miRNA-34a is associated with docetaxel resistance in human breast cancer cells.

Authors:  L Kastl; I Brown; A C Schofield
Journal:  Breast Cancer Res Treat       Date:  2011-03-12       Impact factor: 4.872

Review 6.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

7.  MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.

Authors:  Sirigiri Divijendra Natha Reddy; Kazufumi Ohshiro; Suresh K Rayala; Rakesh Kumar
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

8.  Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.

Authors:  X Li; Y Shen; H Ichikawa; T Antes; G S Goldberg
Journal:  Oncogene       Date:  2009-09-21       Impact factor: 9.867

9.  MicroRNA-mediated regulation of Ubc9 expression in cancer cells.

Authors:  Fangting Wu; Shuomin Zhu; Yanna Ding; William T Beck; Yin-Yuan Mo
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

10.  MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.

Authors:  Yong Liu; Jing Zhao; Pei-Ying Zhang; Yu Zhang; San-Yuan Sun; Shi-Ying Yu; Qing-Song Xi
Journal:  Med Sci Monit       Date:  2012-08
View more
  50 in total

1.  MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer.

Authors:  Lei Huo; Yan Wang; Yun Gong; Savitri Krishnamurthy; Jing Wang; Lixia Diao; Chang-Gong Liu; Xiuping Liu; Feng Lin; William F Symmans; Wei Wei; Xinna Zhang; Li Sun; Ricardo H Alvarez; Naoto T Ueno; Tamer M Fouad; Kenichi Harano; Bisrat G Debeb; Yun Wu; James Reuben; Massimo Cristofanilli; Zhuang Zuo
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.

Authors:  Lizandra Jimenez; Ved P Sharma; John Condeelis; Thomas Harris; Thomas J Ow; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Arch Pathol Lab Med       Date:  2015-07-14       Impact factor: 5.534

3.  miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC.

Authors:  Xiaowei Shen; Jiaqi Lei; Lei Du
Journal:  Exp Ther Med       Date:  2019-11-12       Impact factor: 2.447

Review 4.  MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells.

Authors:  Jeffrey V Brower; Paul A Clark; Will Lyon; John S Kuo
Journal:  Neurochem Int       Date:  2014-06-14       Impact factor: 3.921

5.  miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Authors:  Lizandra Jimenez; Jihyeon Lim; Berta Burd; Thomas M Harris; Thomas J Ow; Nicole Kawachi; Thomas J Belbin; Ruth Angeletti; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2017-05-10       Impact factor: 4.307

6.  miR-141 as potential suppressor of β-catenin in breast cancer.

Authors:  Nairi Abedi; Samira Mohammadi-Yeganeh; Ameneh Koochaki; Fariba Karami; Mahdi Paryan
Journal:  Tumour Biol       Date:  2015-07-13

7.  Involvement of Numb-mediated HIF-1α inhibition in anti-proliferative effect of PNA-antimiR-182 in trastuzumab-sensitive and -resistant SKBR3 cells.

Authors:  Soraya Sajadimajd; Razieh Yazdanparast; Sadeghirizi Akram
Journal:  Tumour Biol       Date:  2015-11-12

Review 8.  MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.

Authors:  Nirav R Shah; Hexin Chen
Journal:  World J Clin Oncol       Date:  2014-05-10

Review 9.  Roles for miRNAs in endocrine resistance in breast cancer.

Authors:  Penn Muluhngwi; Carolyn M Klinge
Journal:  Endocr Relat Cancer       Date:  2015-10       Impact factor: 5.678

10.  Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer.

Authors:  Zhongxing Liang; Xuehai Bian; Hyunsuk Shim
Journal:  Biochem Biophys Res Commun       Date:  2016-06-16       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.